References:
1. Zumla, A., & Maeurer, M. (2015). Host-Directed Therapies for Tuberculosis. Clinical Microbiology Reviews, 28(4), 791-856.
2. Flynn, J. L., & Chan, J. (2001). Immunology of Tuberculosis. Annual Review of Immunology, 19(1), 93-129.
3. Esmail, H., Barry, C. E., & Wilkinson, R. J. (2012). Understanding Latent Tuberculosis: The Key to Improved Diagnostic and Novel Treatment Strategies. Drug Discovery Today, 17(9-10), 514-521.
4. 4 Hunter, R. L. (2016). Pathology of Post Primary Tuberculosis of the Lung: An Illustrated Critical Review. Tuberculosis, 97, 26-42.
5. Gupta, U. D., & Katoch, V. M. (2015). Animal Models of Tuberculosis for Vaccine Development. Indian Journal of Medical Research, 141(4), 505-515.
6. Dheda, K., & Gumbo, T. (2011). Maartens, G. et al. The Epidemiology, Pathogenesis, Transmission, Diagnosis, and Management of Multidrug-Resistant, Extensively Drug-Resistant, and incurable Tuberculosis. The Lancet R